Healio
›
Hematology/Oncology
›
Hematologic Malignancies
›
News
-
FDA approvals
-
-
HemOnc Today, March 25, 2013
-
The FDA today approved the first generic version of the cancer drug doxorubicin hydrochloride liposome injection, used to treat ovarian cancer,...More
»
-
In the Journals
-
-
HemOnc Today, February 25, 2013
-
Idarubicin was associated with better long-term outcomes than high-dose daunorubicin therapy in a cohort of older patients with acute myeloid leukemia,...More
»
-
Meeting News Coverage
-
-
HemOnc Today, February 10, 2013
-
Patients with early-stage Hodgkin’s lymphoma with a negative PET after three cycles of doxorubicin, bleomycin, vinblastine and dacarbazine do not...More
»
-
-
-
HemOnc Today, February 10, 2013
-
The Mario Lemieux Center for Blood Cancers recently welcomed its first visitors at the UPMC CancerCenter’s Hillman Cancer Center in Pittsburgh.
The...More
»
-
-
-
HemOnc Today, February 25, 2013
-
Rainer Storb
ASH recently presented Rainer Storb, MD, with its Mentor Award for Basic Science in recognition of his commitment to the training and career...More
»
-
In the Journals
-
-
HemOnc Today, February 25, 2013
-
Bendamustine is a viable treatment option for heavily pretreated patients with relapsed and refractory Hodgkin’s lymphoma, according to results of a...More
»
-
FDA approvals
-
-
HemOnc Today, March 10, 2013
-
The FDA today approved the use of imatinib to treat children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Acute...More
»
-
In the Journals
-
-
HemOnc Today, February 10, 2013
-
Combined assessment of volume and total lesion glycosis predicted survival outcomes in a cohort of patients with diffuse large B-cell lymphoma, according...More
»
-
In the Journals
-
-
HemOnc Today, January 25, 2013
-
Unfolded protein response inhibition may be effective against cancers characterized by c-Myc overexpression, according to study results.
The unfolded...More
»
-
Meeting News Coverage
-
-
HemOnc Today, January 25, 2013
-
The addition of rituximab to chemotherapy significantly improved OS among patients with follicular lymphoma, according to results of multiple trials...More
»